Customizing nano-chitosan for sustainable drug delivery

M Saeedi, O Vahidi, MR Moghbeli, S Ahmadi… - Journal of Controlled …, 2022 - Elsevier
Chitosan is a natural polymer with acceptable biocompatibility, biodegradability, and
mechanical stability; hence, it has been widely appraised for drug and gene delivery …

Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect?

CJ Clancy, MH Nguyen - Clinical Infectious Diseases, 2020 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) arose at a time of great concern about
antimicrobial resistance (AMR). No studies have specifically assessed COVID-19 …

Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant …

PD Tamma, SL Aitken, RA Bonomo… - Clinical Infectious …, 2021 - academic.oup.com
Background Antimicrobial-resistant infections are commonly encountered in US hospitals
and result in significant morbidity and mortality. This guidance document provides …

Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance

KL LaPlante, A Dhand, K Wright, M Lauterio - Annals of Medicine, 2022 - Taylor & Francis
The progressive increase in antibiotic resistance in recent decades calls for urgent
development of new antibiotics and antibiotic stewardship programs to help select …

[HTML][HTML] Clinical data from studies involving novel antibiotics to treat multidrug-resistant Gram-negative bacterial infections

SS Kanj, M Bassetti, P Kiratisin, C Rodrigues… - International journal of …, 2022 - Elsevier
Abstract Multidrug-resistant (MDR) Gram-negative bacteria (GNB) pose a critical threat to
global healthcare, worsening outcomes and increasing mortality among infected patients …

[PDF][PDF] Infectious Diseases Society of America antimicrobial resistant treatment guidance: gram-negative bacterial infections

PD Tamma, SL Aitken, RA Bonomo, AJ Mathers… - practice, 2020 - kduoc.duytan.edu.vn
The rise in antimicrobial resistance (AMR) continues to be a global crisis [1, 2]. Collectively,
antimicrobial resistant pathogens caused more than 2.8 million infections and over 35,000 …

New perspectives on antimicrobial agents: cefiderocol

EK McCreary, EL Heil, PD Tamma - Antimicrobial agents and …, 2021 - journals.asm.org
Bacterial resistance to carbapenem agents has reached alarming levels. Accordingly,
collaborative efforts between national and international organizations and the …

[HTML][HTML] Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases …

G Tiseo, G Brigante, DR Giacobbe, AE Maraolo… - International Journal of …, 2022 - Elsevier
Management of patients with infections caused by multidrug-resistant organisms is
challenging and requires a multidisciplinary approach to achieve successful clinical …

Encouraging the development of new antibiotics: are financial incentives the right way forward? A systematic review and case study

IA Dutescu, SA Hillier - Infection and drug resistance, 2021 - Taylor & Francis
Antibiotic resistance is an urgent public health threat that has received substantial attention
from the world's leading health agencies and national governmental bodies alike. However …

A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance

L Chen, S Kumar, H Wu - Archives of Microbiology, 2023 - Springer
The emergence and transmission of antibiotic resistance is a global public health crisis with
significant burden on healthcare systems, resulting in high mortality and economic costs. In …